TLSI
TLSI
NASDAQ · Biotechnology

Trisalus Life Sciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$4.75
+0.07 (+1.50%)
As of Feb 8, 2:02 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target -8.8% upside
Low Target $2.61
Average Target $4.33
High Target $5.56
Current Price $4.75
Current
$4.75
Target
$4.33
$2.61 $4.33 avg $5.56
Scenario Analysis
Bear Case
$2.61
-45.1%
Low target
Base Case
$4.33
-8.8%
Avg target
Bull Case
$5.56
+17.1%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$4.06
17.0% from high
52-Week Low
$1.97
+141.1% from low
Target vs 52W High
$4.33
+6.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%